Form 6-K NOVARTIS AG For: Oct 27
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- ICC sets July 24 vote on whether to remove chief prosecutor Karim Khan, WSJ reports
Novartis Q3 preview: BofA sees strong product momentum, potential EBIT Upgrade
October 27, 2025 4:00 PM EDTNovartis (NYSE: NVS) is set to report third-quarter results that Bank of America expects will be broadly in line with consensus, underpinned by strong prescription trends for key growth drivers.
According to BofA analyst Sachin Jain, the Neutral-rated drugmakers Q3 earnings per share are forecast at $2.30, up 12% year-on-year, on sales of about $14... More
